Clinical Trial: Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: An Open-label Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316, an Anti-C5 Monoclonal Antibody in Patients With Paroxysmal Nocturnal Hemoglobi

Brief Summary: To determine whether LFG316 can induce a hematological response, as measured by reduction in hemolytic activity, in patients with PNH.